Recent Developments in the Stem Cell Market – PR Newswire (press release)
Scope (blog) |
Recent Developments in the Stem Cell Market
PR Newswire (press release) According to Grand View Research, Inc., the global stem cell market is projected to reach a value of USD 15.63 billion by 2025, while growing at a CAGR of 9.2%. The increasing number of research studies that aim at broadening the scope of stem cells … Where bioengineering and stem cell science meet, and thriveScope (blog) Stem Cell Treatment Aiding Cells After Heart AttackAnti Aging News Everything You Need to Know About Tarek El Moussa’s Controversial Stem Cell Treatment for His Back PainThe Cheat Sheet Korea Biomedical Review –Expert Consulting all 330 news articles » |
Scope (blog) |
Recent Developments in the Stem Cell Market
PR Newswire (press release) According to Grand View Research, Inc., the global stem cell market is projected to reach a value of USD 15.63 billion by 2025, while growing at a CAGR of 9.2%. The increasing number of research studies that aim at broadening the scope of stem cells … Where bioengineering and stem cell science meet, and thriveScope (blog) Stem Cell Treatment Aiding Cells After Heart AttackAnti Aging News Everything You Need to Know About Tarek El Moussa’s Controversial Stem Cell Treatment for His Back PainThe Cheat Sheet Korea Biomedical Review –Expert Consulting all 330 news articles » |
Seeking Alpha |
3 Things In Biotech, May 21: A Powerful New Immunotherapy?
Seeking Alpha Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Try for free today and see what we’re talking about! Here is some more information if you’re curious. Welcome to another edition of “3 Things In … |
Endpoints News |
Buoyed by new data on hemophilia A gene therapy, BioMarin boosts enrollment in head-to-head study
Endpoints News And the biotech now plans to boost the number of patients in a registration study so they can provide clear evidence of the gene therapy’s ability to beat the current standard of care using factor replacement therapy. The company will boost enrollment … BioMarin Provides 2 Years of Clinical Data in 6e13 vg/kg Dose from Ongoing Phase 1/2 Study in Valoctocogene …PR Newswire (press release) BioMarin Pharma (BMRN) Reports 2-Yr Clinical Data from Ongoing Phase 1/2 Study in Valoctocogene Roxaparvovec …StreetInsider.com BioMarin’s valoctocogene roxaparvovec shows long-term treatment effect in hemophilia A studySeeking Alpha |
Phys.Org |
Toward a stem cell model of human nervous system development
Phys.Org In the new study, Fu’s research team arranged human embryonic stem cells into circular cell colonies with defined shapes and sizes. The cells were then exposed to chemicals known to coax them to differentiate into neural cells. During the … Kyoto University to start providing Embryonic Stem cells for clinical studiesNikkei Asian Review |